Skip navigation

Pharmacometabonomics: An important new paradigm for precision medicine

Pharmacometabonomics: An important new paradigm for precision medicine

Everett, Jeremy (2014) Pharmacometabonomics: An important new paradigm for precision medicine. In: Metabomeeting 2014, 10-12 Sep 2014, The Royal Institution, London, UK. (Unpublished)

[img] PDF (Agenda)
12154_EVERETT_Metabomeeting_2014_(Agenda).docx - Supplemental Material

Download (213kB)
[img]
Preview
PDF
12154_EVERETT__PMx_MetaboMeeting_September_2014_nbu_(Presentation).pdf - Presentation
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (1MB)

Abstract

Many medicines are ineffective or unsafe in significant portions of their patient populations. A key thrust for 21st Century healthcare is to develop more personalized drug treatments such that patients receive medicines that both efficacious and safe. This paradigm is also known as precision medicine. Current personalised medicine approaches rely heavily on the analysis of the genomes of the patients or the organisms that infect them. However, this approach has had less impact and success than was anticipated. Metabonomics is a new ‘omics science that is concerned with the analysis of metabolite profiles, especially in animal or human biofluids or tissues, and the response of those metabolite profiles to interventions such as exercise, drug treatment or gene mutation. Interest in metabonomics is very high at present as it is realized that metabolite profiles are influenced not just by genetic factors but also by environmental factors such as nutrition, health status and critically, microbiome composition. Pharmacometabonomics is an even newer development that enables the prediction of the metabolism, safety, efficacy or pharmacokinetics of a drug in an animal or human, based on analysis of pre-dose metabolic profiles. This talk will cover both the development and applications of pharmacometabonomics in pre-clinical and clinical settings and explore its utility in personalized medicine.

Item Type: Conference or Conference Paper (Keynote)
Additional Information: [1] Keynote paper, given at the Metabomeeting 2014, 10-12 September 2014, The Royal Institution, London, UK.
Uncontrolled Keywords: metabonomics, pharmacometabonomics, precision personalised medicine
Subjects: R Medicine > R Medicine (General)
R Medicine > RM Therapeutics. Pharmacology
Faculty / Department / Research Group: Faculty of Engineering & Science
Faculty of Engineering & Science > Department of Pharmaceutical, Chemical & Environmental Sciences
Related URLs:
Last Modified: 17 Oct 2016 09:12
Selected for GREAT 2016: None
Selected for GREAT 2017: None
Selected for GREAT 2018: None
URI: http://gala.gre.ac.uk/id/eprint/12154

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics